Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDAMA health claim provisions

This article was originally published in The Tan Sheet

Executive Summary

FDA guidance on health claims section of the FDA Modernization Act to be available "very shortly," FDA Office of Food Labeling Director of Technical Evaluation Virginia Wilkening says at a meeting in Washington, D.C. April 30. FDAMA allows food manufacturers to make health claims based on authoritative statements of government scientific bodies, such as the Centers for Disease Control & Prevention or the National Institutes of Health, without FDA approval ("The Tan Sheet" Jan. 19, p. 13). The guidance is expected to address whether the provision would apply to dietary supplements. Implementing regs will follow the guidance, Wilkening said...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088397

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel